Company DescriptionBiodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease.

Proceeds PurposesThe investment will be used for ongoing new product development and expansion of commercial efforts to support Biodesix’ commercialized products, VeriStrat and GeneStrat, as well as new product launches in 2015 – 2016.